Covid-19 roundup: FDA commissioners call for more ‘concerted effort’ on convalescent plasma R&D; Regeneron boosts case for antibody cocktail with new animal data
Four former FDA commissioners have coalesced around a century-old treatment they believe can give the best weapon against Covid-19: Convalescent plasma.
Writing in The Washington Post, former FDA commissioners Mark McClellan, Margaret Hamburg, Robert Califf and Scott Gottlieb said that while more work needs to be done to prove it’s safe and effective, convalescent plasma was a “promising treatment” that “could help millions of patients with the novel coronavirus both here and abroad.” They warned, though, that for it to become an effective tool in the US’ Covid-19 response, a more “concerted effort” is needed to recruit donors and run trials.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
